EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Profiling of the T Cell Receptor Repertoire Reveals Different Immunological Signatures Between Mild and Severe H1N1 Infection

Jiezuan Yang, Xuehui Zhao, Dangsheng Xiao, Hua Zhang, Haifeng Lu

APMIS · 2026-11 · 134 (11)

DOI: 10.1111/apm.70282 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Severe H1N1 influenza remains a global health concern, but the immunological mechanisms underlying disease severity are not fully understood. In this study, we used high‐throughput sequencing to profile the T cell receptor beta chain (TRB) complementarity‐determining region 3 (CDR3) repertoire in 24 H1N1 patients (12 mild, 12 severe) during the 2009 pandemic. Our analysis revealed significant differences in TRB diversity and clonal expansion between severity groups. Severe patients had significantly reduced TRBV11‐3 usage and overall TRB diversity, as indicated by lower Shannon entropy and fewer clonotypes. Twelve TRBV‐BJ combinations were downregulated, whereas one was upregulated in severe cases. Similarly, 20 V‐D‐J combinations were significantly less frequent, and two were more prevalent in severe patients. Severe infection was associated with a higher proportion of hyper‐expanded clones, indicating an intense oligoclonal T cell response that narrows repertoire diversity. These characteristic CDR3 repertoire changes provide important insights into the immunopathogenesis of severe influenza and may inform the development of new diagnostic approaches and T cell‐targeted therapies. Our findings highlight the value of TCR repertoire profiling for stratifying disease severity and guiding future research on emerging influenza viruses, with potential for translating immunological insights into clinical applications.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →